Daewoong
Nabota
Brand
Daewoong
Category
Botulinum Toxin
Origin
Korea
Options
100 unit · 200 unit
Available options
Interested in ordering Nabota? Send an enquiry and our team will follow up with availability and pricing.
Overview
Nabota is a botulinum toxin type A developed by Daewoong Pharmaceutical of South Korea, produced with a proprietary high-purity manufacturing process. The same product is marketed as Jeuveau in the US and Canada and as Nuceiva in Europe and Australia. It is positioned as a highly purified, preservative-free aesthetic neurotoxin.
How it works
It acts as a type A botulinum toxin, cleaving SNAP-25 to inhibit acetylcholine release at the neuromuscular junction and temporarily relax the targeted muscle. The effect is dose-dependent and reversible.
Indications
- Glabellar (frown) lines
- Forehead lines
- Crow's feet
- Masseter / jaw slimming
- Hyperhidrosis
Key features
- High-purity proprietary purification process
- Preservative-free formulation
- Lyophilised powder for reconstitution
- Same molecule as Jeuveau / Nuceiva
- Refrigerated storage
Benefits
- High-purity toxin with international regulatory footprint
- Preservative-free for sensitive patients
- Backed by an internationally approved equivalent (Jeuveau/Nuceiva)
- Consistent, predictable aesthetic performance
Composition
Active ingredient is Clostridium botulinum toxin type A (approximately 900 kDa complex), with human serum albumin and sodium chloride as excipients; the formulation is preservative-free. Supplied as a lyophilised powder, commonly in a 100 U vial, produced via Daewoong's proprietary high-purity purification technology.
Usage & handling
Reconstitute with preservative-free 0.9% saline before injection. Store refrigerated at 2-8C and use within the recommended window after reconstitution. Units are product-specific and not interchangeable with other toxins.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.